Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement
Minghao Zhong
, Paul Weisman
, Bing Zhu
, Maria Brassesco
, Youfeng Yang
, W. Marston Linehan
, Maria J. Merino
,
David Zhang
, Stephen Rohan
, Dongming Cai
, Ximing Yang
Icahn School of Medicine at Mount Sinai
Pathology, Molecular and Cell-Based Medicine
Friedman Brain Institute
Graduate School of Biomedical Sciences
Neurology
Ronald M. Loeb Center for Alzheimer’s Disease
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Transcription Factor E3 (TFE3)
100%
Translocation Renal Cell Carcinoma
100%
Immunoreactivity
40%
TFE3 Gene
40%
Immunohistochemistry
30%
Tumor
20%
Quantitative PCR
20%
Pathologist
20%
Sanger Sequencing
20%
Fusion Protein
20%
Cytoplasmic Localization
20%
Exon 9
20%
Gene Rearrangement
10%
Sequence Analysis
10%
Histopathological Examination
10%
Diagnostic Marker
10%
Exon 5
10%
Xp11.2
10%
Exon 6
10%
Fresh Frozen Tissue
10%
Cytogenetic Assay
10%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Immunoreactivity
57%
Exon
57%
Immunohistochemistry
42%
Cell Line
42%
Pathologist
28%
Sanger Sequencing
28%
Gene Fusion
28%
Chimeric Protein
28%
Reverse Transcription Polymerase Chain Reaction
28%
Neoplasm
14%
Diagnostic Marker
14%
Gene Rearrangement
14%
Tumor
14%
Biochemistry, Genetics and Molecular Biology
TFE3
100%
Exon
28%
Immunoreactivity
28%
Gene Fusion
14%
Chimeric Protein
14%
Dideoxynucleotide Sequencing
14%
Reverse Transcription Polymerase Chain Reaction
14%
Cytogenetics
7%
Gene Rearrangement
7%
Veterinary Science and Veterinary Medicine
Renal Cell Carcinoma
100%
Immunohistochemistry
42%
Reverse Transcription Polymerase Chain Reaction
28%
Neoplasm
14%
Tumor
14%